Revolution Medicines (RVMD) Tax Provisions (2020 - 2024)
Revolution Medicines' quarterly Tax Provisions came in at -$753000.0 in Q4 2024, down 117.97% year-on-year from $4.2 million in Q1 2024, and down 117.97% quarter-over-quarter from $4.2 million in Q4 2023.
Revolution Medicines has reported Tax Provisions for 4 years, with the latest figure at -$753000.0 in Q4 2024.
- For the quarter ending Q4 2024, Tax Provisions fell 117.97% year-over-year to -$753000.0; the trailing twelve-month figure through Dec 2024 stood at -$753000.0 (down 332.41% YoY), and the FY2024 full-year result was -$753000.0, down 332.41% from the prior year.
- Tax Provisions for Q4 2024 stood at -$753000.0, down from $4.2 million in the prior quarter.
- The five-year high for Tax Provisions was $4.2 million in Q4 2023, with the low at -$3.9 million in Q3 2023.
- Average Tax Provisions over 4 years is -$150000.0, with a median of -$200000.0 recorded in 2022.
- Peak annual rise in Tax Provisions reached 4168.93% in 2023, while the deepest fall reached 1202.02% in 2023.
- Tracing RVMD's Tax Provisions over 4 years: stood at $362000.0 in 2020, then tumbled by 128.45% to -$103000.0 in 2022, then jumped by 4168.93% to $4.2 million in 2023, then slumped by 117.97% to -$753000.0 in 2024.
- The last three Tax Provisions figures came in at -$753000.0 (Q4 2024), $4.2 million (Q4 2023), and -$3.9 million (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -753,000.00 |
| Dec 31, 2023 | 4.19 Mn |
| Sep 30, 2023 | -3.87 Mn |
| Dec 31, 2022 | -103,000.00 |
| Sep 30, 2022 | -297,000.00 |
| Dec 31, 2020 | 362,000.00 |
| Jun 30, 2020 | -58,000.00 |
| Mar 31, 2020 | -675,000.00 |